Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
European Journal of Cancer
Published October 9, 2026
Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcino...
October 14, 2026
Medspoke
Medspoke
The Oncologist
Published October 13, 2026
00:00
--:--
Durable Response to Vebreltinib in Heavily Pretreated MET-Amplified Intrahepatic Cholangiocarcino...
October 14, 2026
Share
Durable Response to Vebreltinib in Heavily Pretreated MET-Amplified Intrahepatic Cholangiocarcinoma: A Case Report.
https://www.medspoke.co/channel_journal?id=785&tap_id=15534
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Leukemia
Published October 12, 2026
Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in...
October 13, 2026
Why are you reporting this TALK?
